{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:20Z","timestamp":1790846660153,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1093\/schbul\/sbr202","type":"journal-article","created":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T02:08:18Z","timestamp":1327630098000},"page":"648-657","source":"Crossref","is-referenced-by-count":141,"title":["Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia"],"prefix":"10.1093","volume":"39","author":[{"given":"Chian-Jue","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Tang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Shau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Tung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Chicy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"key\n\t\t\t\t20170512041302_bib1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(03)13306-5","article-title":"New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis","volume":"361","author":"Leucht","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170512041302_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200418130-00004","article-title":"Impact of atypical antipsychotics on quality of life in patients with schizophrenia","volume":"18","author":"Awad","year":"2004","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t20170512041302_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170512041302_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4088\/JCP.09m05402yel","article-title":"Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study","volume":"72","author":"Bai","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1176\/ajp.2006.163.7.1132","article-title":"Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?","volume":"163","author":"Remington","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1532-5415.2007.01625.x","article-title":"Antipsychotic drug use and risk of pneumonia in elderly people","volume":"56","author":"Knol","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t20170512041302_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7326\/0003-4819-152-7-201004060-00006","article-title":"Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study","volume":"152","author":"Trifiro","year":"2010","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170512041302_bib11","volume-title":"Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioural Disturbances. Silver Spring, MD: U.S. Food and Drug Administration; 2005.","author":"U.S. Food and Drug Administration"},{"key":"key\n\t\t\t\t20170512041302_bib12","volume-title":"FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs","author":"U.S. Food and Drug Administration","year":"2008"},{"key":"key\n\t\t\t\t20170512041302_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.jcp.0000203598.43314.34","article-title":"Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients","volume":"26","author":"Barnett","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20170512041302_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.clpt.6100069","article-title":"Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study","volume":"81","author":"Yang","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170512041302_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11908-011-0175-y","article-title":"Antipsychotic drug use and community-acquired pneumonia","volume":"13","author":"Trifiro","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"key\n\t\t\t\t20170512041302_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v69n0314","article-title":"Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial","volume":"69","author":"McElroy","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/15622970410029938","article-title":"Reversible neutropenia during treatment with olanzapine: three case reports","volume":"5","author":"Cordes","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1192\/bjp.bp.108.051979","article-title":"Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection","volume":"194","author":"Taylor","year":"2009","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/schbul\/sbq019","article-title":"Poor Clinical Outcomes Among Pneumonia Patients With Schizophrenia","volume":"37","author":"Chen","year":"2011","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20170512041302_bib20","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.1992.03490170060026","article-title":"Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland","volume":"268","author":"Weissman","year":"1992","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170512041302_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1176\/appi.ajp.2010.10071064","article-title":"Association of cerebrovascular events with antidepressant use: a case-crossover study","volume":"168","author":"Wu","year":"2011","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JCP.0b013e3181845610","article-title":"The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study","volume":"28","author":"Gau","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20170512041302_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1399-5618.2010.00814.x","article-title":"Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study","volume":"12","author":"Gau","year":"2010","journal-title":"Bipolar Disord"},{"key":"key\n\t\t\t\t20170512041302_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/JCP.0b013e3181723713","article-title":"A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in Taiwan","volume":"28","author":"Gau","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20170512041302_bib25","volume-title":"ATC index with DDDs","author":"WHO Collaborating Centre for Drug Statistic Methodology","year":"2009"},{"key":"key\n\t\t\t\t20170512041302_bib26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0895-4356(01)00396-1","article-title":"Comparison of different methods to estimate prevalence of drug use by using pharmacy records","volume":"54","author":"Mantel-Teeuwisse","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20170512041302_bib27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170512041302_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1472-6963-11-146","article-title":"Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts","volume":"11","author":"Quail","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"key\n\t\t\t\t20170512041302_bib29","first-page":"516","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"79","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t20170512041302_bib30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170512041302_bib31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170512041302_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2009.03.002","article-title":"Increased use of antibiotics in patients treated with clozapine","volume":"19","author":"Nielsen","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20170512041302_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2004-818993","article-title":"Esophageal dysfunction on psychotropic medication. A case report and literature review","volume":"37","author":"Maddalena","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00004714-199612000-00013","article-title":"Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea","volume":"16","author":"Hinkes","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t20170512041302_bib35","volume-title":"Harrison's Principles of Internal Medicine","author":"Fauci","year":"2008","edition":"17th ed"},{"key":"key\n\t\t\t\t20170512041302_bib36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4088\/JCP.10r06264yel","article-title":"Past and present progress in the pharmacologic treatment of schizophrenia","volume":"71","author":"Kane","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20170512041302_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000026556","article-title":"Amisulpride versus amineptine and placebo for the treatment of dysthymia","volume":"39","author":"Boyer","year":"1999","journal-title":"Neuropsychobiology"},{"key":"key\n\t\t\t\t20170512041302_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0327(97)00139-0","article-title":"Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study","volume":"48","author":"Smeraldi","year":"1998","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20170512041302_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1378\/chest.116.2.375","article-title":"Proportion of community-acquired pneumonia cases attributable to tobacco smoking","volume":"116","author":"Almirall","year":"1999","journal-title":"Chest"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/39\/3\/648\/16975373\/sbr202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T07:07:36Z","timestamp":1503558456000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-lookup\/doi\/10.1093\/schbul\/sbr202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,1,26]]},"published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbr202","relation":{},"ISSN":["1745-1701","0586-7614"],"issn-type":[{"value":"1745-1701","type":"electronic"},{"value":"0586-7614","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}